Rallybio (RLYB) Equity Ratio (2022 - 2026)
Rallybio's Equity Ratio history spans 4 years, with the latest figure at 0.93 for Q4 2025.
- On a quarterly basis, Equity Ratio rose 2.83% to 0.93 in Q4 2025 year-over-year; TTM through Dec 2025 was 0.93, a 2.83% increase, with the full-year FY2025 number at 0.93, up 2.83% from a year prior.
- Equity Ratio hit 0.93 in Q4 2025 for Rallybio, roughly flat from 0.93 in the prior quarter.
- Over the last five years, Equity Ratio for RLYB hit a ceiling of 0.96 in Q1 2023 and a floor of 0.87 in Q2 2024.
- Historically, Equity Ratio has averaged 0.92 across 4 years, with a median of 0.93 in 2023.
- Biggest five-year swings in Equity Ratio: decreased 8.26% in 2024 and later increased 4.1% in 2025.
- Tracing RLYB's Equity Ratio over 4 years: stood at 0.94 in 2022, then decreased by 2.13% to 0.92 in 2023, then fell by 1.43% to 0.91 in 2024, then grew by 2.83% to 0.93 in 2025.
- Business Quant data shows Equity Ratio for RLYB at 0.93 in Q4 2025, 0.93 in Q3 2025, and 0.9 in Q2 2025.